1. Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study
    Luis Paz-Ares et al, 2023, Journal of Clinical Oncology CrossRef
  2. Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
    Apar Kishor P. Ganti et al, 2021, Journal of the National Comprehensive Cancer Network CrossRef
  3. Sequential chemotherapy and icotinib as first-line treatment for advanced epidermal growth factor receptor-mutated non-small cell lung cancer
    Sheng-Jie Sun et al, 2022, World Journal of Clinical Cases CrossRef
  4. Inhibition of SARS-CoV-2 Nsp9 ssDNA-Binding Activity and Cytotoxic Effects on H838, H1975, and A549 Human Non-Small Cell Lung Cancer Cells: Exploring the Potential of Nepenthes miranda Leaf Extract for Pulmonary Disease Treatment
    Hsin-Hui Su et al, 2024, International Journal of Molecular Sciences CrossRef
  5. Burden of chemotherapy‐induced myelosuppression among patients with extensive‐stage small cell lung cancer: A retrospective study from community oncology practices
    Lowell Hart et al, 2023, Cancer Medicine CrossRef
  6. Cytotoxicity and Multi-Enzyme Inhibition of Nepenthes miranda Stem Extract on H838 Human Non-Small Cell Lung Cancer Cells and RPA32, Elastase, Tyrosinase, and Hyaluronidase Proteins
    Ching-Yi Lee et al, 2024, Plants CrossRef
  7. A Single-Arm Multi-Center Phase II Clinical Trial of Cadonilimab (anti-PD-1/CTLA-4) in Combination with or without Conventional Second-Line Treatment for Patients with Extensive Stage Small Cell Lung Cancer
    Can Chen et al, 2024, Technology in Cancer Research & Treatment CrossRef
  8. Evaluation of Real-Life Chemoimmunotherapy Combination in Patients with Metastatic Small Cell Lung Carcinoma (SCLC): A Multicentric Case–Control Study
    Rémy Ezzedine et al, 2023, Cancers CrossRef
  9. Unweaving the mitotic spindle: A focus on Aurora kinase inhibitors in lung cancer
    Alessio Stefani et al, 2022, Frontiers in Oncology CrossRef
  10. Interaction of Camptothecin Anticancer Drugs with Ribosomal Proteins L15 and L11: A Molecular Docking Study
    Christian Bailly et al, 2023, Molecules CrossRef